Reducing Polypharmacy: Evidence From a Simple Quality Improvement Initiative

Journal of the American Medical Directors Association

Volumn 14, Issue 3, 2013, Pages 152-156

  Little, Milta O ^a   Morley, Alexis ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Network HealthCare Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSULTATION; COST BENEFIT ANALYSIS; COST CONTROL; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FRAIL ELDERLY; GERIATRIC PATIENT; HOSPITAL READMISSION; HUMAN; LONG TERM CARE; MEDICAL EDUCATION; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; NURSING HOME; PATIENT CARE; PHARMACY; POLYPHARMACY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOTAL QUALITY MANAGEMENT; WEIGHT REDUCTION;

EID: 84874265822     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2012.11.007     Document Type: Editorial

References (26)

1. Planton J., Edlund B.J. Strategies for reducing polypharmacy in older adults. J Gerontol Nurs 2010, 36:8-12.
2. Jyrkka J., Enlund H., Korhonen M.J., et al. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009, 26:1039-1048.
3. Beer C., Hyde Z., Almeida O.P., et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men: An observational study. Br J Clin Pharmacol 2011, 71:592-599.
4. Field T.S., Gurwitz J.H., Harrold L.R., et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004, 52:1349-1354.
5. Bronskill S.E., Gill S.S., Paterson J.M., et al. Exploring variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc 2012, 13:309.e15-309.e21.
6. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatments-implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010, 11:475-484.
7. Bootman J.L., Harrison D.L., Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997, 157:2089-2096.
8. Thompson J.F., McGhan W.F., Ruffalo R.L., et al. Clinical pharmacists prescribing drug therapy in a geriatric setting: Outcome of a trial. J Am Geriatr Soc 1984, 32:154-159.
9. Roberts M.S., Stokes J.A., King M.A., et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001, 51:257-265.
10. Blozik E., Born A.M., Stuck A.E., et al. Reduction of inappropriate medications among older nursing-home residents: A nurse-led, pre/post-design, intervention study. Drugs Aging 2010, 27:1009-1017.
11. Tamura B.K., Bell C.L., Lubimir K., et al. Physician intervention for medication reduction in a nursing home: The polypharmacy outcomes project. J Am Med Dir Assoc 2011, 12:326-330.
12. Kojima G., Bell C., Tamura B., et al. Reducing cost by reducing polypharmacy: The polypharmacy outcomes project. J Am Med Dir Assoc 2012, 13:818.e11-818.e15.
13. Khunti K., Kinsella B. Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents. Age Ageing 2000, 29:451-453.
14. Olsson I.N., Curman B., Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf 2010, 19:150-157.
15. Trygstad T.K., Christensen D.B., Wegner S.E., et al. Analysis of the North Carolina long-term care polypharmacy initiative: A multiple-cohort approach using propensity-score matching for both evaluation and targeting. Clin Ther 2009, 31:2018-2037.
16. Christensen D., Trygstad T., Sullivan R., et al. A pharmacy management intervention for optimizing drug therapy for nursing home patients. Am J Geriatr Pharmacother 2004, 2:248-256.
17. Trygstad T.K., Christensen D., Garmise J., et al. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: Results from the North Carolina polypharmacy initiative. J Manag Care Pharm 2005, 11:575-583.
18. Westbury J., Tichelaar L., Peterson G., et al. A 12-month follow-up study of "RedUSe": a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr 2011, 23:1260-1269.
19. Levenson S.A., Saffel D.A. The consultant pharmacist and the physician in the nursing home: Roles, relationships, and a recipe for success. J Am Med Dir Assoc 2007, 8:55-64.
20. Scott I.A., Gray L.C., Martin J.H., Mitchell C.A. Minimizing inappropriate medications in older populations: A 10-step conceptual framework. Am J Med 2012, 125:529-537.e4.
21. Meyer T.J., Van Kooten D., Marsh S., Prochazka A.V. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991, 6:133-136.
22. Gallagher P., Baeyens J.P., Topinkova E., et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons' Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009, 38:603-606.
23. Gallagher P., O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37:673-679.
24. Gallagher P., Ryan C., Byrne S., et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008, 46:72-83.
25. Updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012, 60:616-631. American Geriatrics Society.
26. Gokula M., Holmes H.M. Tools to reduce polypharmacy. Clin Geriatr Med 2012, 28:323-341.